The HPMC market growth is being driven by expanding application demand across pharmaceuticals, construction, food processing, and personal care industries worldwide. The market reached USD 5.53 billion in 2025 and is forecast to reach USD 7.58 billion by 2035, growing at a CAGR of 3.20% over the 2026-2035 period. Pharmaceutical tablet coating and controlled-release formulations remain the dominant demand anchor, while construction applications in tile adhesives and dry-mix mortars contribute consistent volume across emerging market building activity.Key Growth Drivers:
Pharmaceutical Formulation Demand. HPMC serves as a critical excipient in tablet binding, film coating, and extended-release drug delivery systems. Expanding generic drug manufacturing across Asia and rising demand for modified-release oral formulations in developed markets are keeping pharmaceutical-grade HPMC procurement on a steady upward path.
Get a Free Sample Report with Table of Contents: Click Here
Construction Sector Consumption. Dry-mix mortar, tile adhesive, and wall putty formulations rely on HPMC as a water retention and workability agent. Infrastructure expansion across India, Southeast Asia, and the Middle East is generating consistent construction-grade HPMC demand that offsets slower growth in mature Western markets.
Cosmetics and Personal Care Adoption. Formulators are increasingly specifying HPMC in lotions, creams, and shampoos for its texture-enhancing, moisture-retention, and skin-feel properties. The clean-label movement in personal care is also favoring HPMC as a plant-derived, non-ionic polymer compatible with natural and organic product positioning.
Emerging Trends:
High-purity pharmaceutical-grade HPMC variants with tighter viscosity specifications are seeing stronger demand growth than standard construction grades, reflecting the overall premiumization of drug delivery applications. Capsule-grade HPMC is gaining share against gelatin alternatives as vegetarian and halal dietary preferences reshape pharmaceutical packaging decisions globally. In construction, formulators are developing low-dust HPMC granules that improve handling safety and reduce waste during dry-mix production, responding to tightening occupational health standards across European manufacturing facilities.
Competitive Landscape:
ShinEtsu (SE Tylose GmbH & Co. KG) produces pharmaceutical, construction, and food-grade HPMC products with manufacturing operations spanning Asia and Europe.
Ashland supplies specialty HPMC grades for pharmaceutical film coating, controlled release, and personal care formulation applications across global markets.
Dow develops cellulose ether solutions including HPMC for construction, pharmaceutical, and food industry applications through its materials science portfolio.
LOTTE Fine Chemical manufactures HPMC and cellulose ether products serving construction and industrial markets primarily across Asia Pacific.
Outlook:
HPMC market growth through 2035 will be shaped by pharmaceutical pipeline expansion, construction activity in emerging economies, and rising personal care ingredient demand. Analysts expect investment to concentrate in high-purity pharmaceutical grades and capsule applications as manufacturers respond to both regulatory requirements and shifting consumer dietary preferences across global drug and supplement markets.